Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU176
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,159
Award facts
- Contract value 100% obligated
- $25,158.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,158.51 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 mg/10 mL vials of Imfinzi, an oncology therapeutic. The delivery order, issued on November 25, 2025, with an ultimate completion date of December 17, 2025, represents a single shipment under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. This non-competitive delivery order draws from the prime pharmaceutical vendor contract that enables AmerisourceBergen to supply military and veteran healthcare systems with brand-name and generic pharmaceuticals, specialty medications, vaccines, and medical supplies across multiple therapeutic domains on a global basis.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal healthcare vendor. The company maintains significant pharmaceutical supply relationships with the Defense Health Agency and other government healthcare systems through its DLA prime contract, which positions it to respond efficiently to urgent medical procurement needs for the military healthcare enterprise. This award demonstrates the company's role in supporting military readiness through the timely delivery of oncological therapeutics necessary for comprehensive medical care across the Defense Department.
Quick answers
Who was awarded contract SPE2DR26FU176?
SPE2DR26FU176 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FU176 worth?
The government has obligated $25,159 on SPE2DR26FU176.
Is contract SPE2DR26FU176 an order under another contract?
Yes. SPE2DR26FU176 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU176 competed?
The extent of competition for SPE2DR26FU176 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award